tirzepatide rebound weight gain After Stopping Tirzepatide: Clinical Causes – PlexusDx Science Pulse | People Who

Fatigue can occur during tirzepatide treatment, particularly in the first weeks as your body adjusts to the medication

By forming a complex with bile acids that cannot be absorbed by the body, cholestyramine prevents recycling of bile acid through the process of enterohepatic recirculation

View Chris Kressers profile on LinkedIn, a professional community of 1 billion members.

However, cardiovascular safety trials in type 2 diabetes patients, the majority presenting cardiovascular disease and excess weight, showed that GLP-1 receptor agonists were indeed capable of decreasing cardiovascular risk

This case report details a 47-year-old male with a history of obesity and T2DM who presented with anecchymotic, petechial rash within a week of increasing the dose of tirzepatide to12.5 mg

PlexusDx explains which decongestants, antihistamines, and cough suppressants are safe to combine with GLP-1 therapy and when to contact your provider